Danylo O. Zavodovskiy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Danylo O. Zavodovskiy has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Andriy V. Maznychenko
Department of Physical Education, Gdansk University of Physical Education and Sport, Kazimierza Gorskiego Str. 1, 80-336 Gdansk, Poland
2 shared publications - Oleg Tsupykov
Department of Cytology, Bogomoletz Institute of Physiology, Kyiv, Ukraine
2 shared publications - Alina Ustymenko
Laboratory of Pathophysiology and Immunology , Chebotarev State Institute of Gerontology of the National Academy of Medical Sciences of Ukraine , Kyiv , Ukraine
1 shared publication D. A. Vasylenko
Department of Movement Physiology, Bogomolets Institute of Physiology, National Academy of Sciences, Kyiv, Ukraine
1 shared publicationI. O. Govbakh
Kharkiv Medical Academy of Postgraduate Education, Ministry of Public Health of Ukraine, Kharkiv, Ukraine
1 shared publication- Inna Sokolowska
Department of Physical Education, Gdansk University of Physical Education and Sport, Kazimierza Gorskiego Str. 1, 80-336 Gdansk, Poland
1 shared publication
Latest Publications
- Open Access
- 6 November 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (21) , 12026
Stem Cell Therapy Enhances Motor Activity of Triceps Surae Muscle in Mice with Hereditary Peripheral Neuropathy
Impaired motor and sensory functions are the main features of Charcot–Marie–Tooth disease. Mesenchymal stem cell (MSCs) therapy is one of the possible treatments for this disease. It was assumed that MSCs therapy can improve the contractile properties of the triceps surae (TS) muscles in mice with hereditary peripheral neuropathy. Murine adipose-derived mesenchymal stromal cells (AD-MSCs) were obtained for transplantation into TS muscles of FVB-C-Tg(GFPU)5Nagy/J mice. Three months after AD-MSCs transplantation, animals were subjected to electrophysiological investigations. Parameters of TS muscle tension after intermittent high frequency electrical sciatic nerve stimulations were analyzed. It was found that force of TS muscle tension contraction in animals after AD-MSCs treatment was two-time higher than in untreated mice. Normalized values of force muscle contraction in different phases of electrical stimulation were 0.3 ± 0.01 vs. 0.18 ± 0.01 and 0.26 ± 0.03 vs. 0.13 ± 0.03 for treated and untreated animals, respectively. It is assumed that the two-fold increase in TS muscle strength was caused by stem cell therapy. Apparently, AD-MSCs therapy can promote nerve regeneration and partial restoration of muscle function, and thus can be a potential therapeutic agent for the treatment of peripheral neuropathies.
- 6 November 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (21) , 12026
Open AccessStem Cell Therapy Enhances Motor Activity of Triceps Surae Muscle in Mice with Hereditary Peripheral Neuropathy
Impaired motor and sensory functions are the main features of Charcot–Marie–Tooth disease. Mesenchymal stem cell (MSCs) therapy is one of the possible treatments for this disease. It was assumed that MSCs therapy can improve the contractile properties of the triceps surae (TS) muscles in mice with hereditary peripheral neuropathy. Murine adipose-derived mesenchymal stromal cells (AD-MSCs) were obtained for transplantation into TS muscles of FVB-C-Tg(GFPU)5Nagy/J mice. Three months after AD-MSCs transplantation, animals were subjected to electrophysiological investigations. Parameters of TS muscle tension after intermittent high frequency electrical sciatic nerve stimulations were analyzed. It was found that force of TS muscle tension contraction in animals after AD-MSCs treatment was two-time higher than in untreated mice. Normalized values of force muscle contraction in different phases of electrical stimulation were 0.3 ± 0.01 vs. 0.18 ± 0.01 and 0.26 ± 0.03 vs. 0.13 ± 0.03 for treated and untreated animals, respectively. It is assumed that the two-fold increase in TS muscle strength was caused by stem cell therapy. Apparently, AD-MSCs therapy can promote nerve regeneration and partial restoration of muscle function, and thus can be a potential therapeutic agent for the treatment of peripheral neuropathies.
- 1 September 2019
- Published by Springer Nature in Neurophysiology
- Vol. 51 (5) , 353-357
Coordination of Locomotor Activity in Transgenic C57Bl/6 Mice with Hereditary Neuropathy
- 1 September 2019
- Published by Springer Nature in Neurophysiology
- Vol. 51 (5) , 353-357
Coordination of Locomotor Activity in Transgenic C57Bl/6 Mice with Hereditary Neuropathy